Fujian Cosunter Pharmaceutical competitive analysis

Latest publications and patents of Fujian Cosunter Pharmaceutical New

Explore the latest publications and patents granted to Fujian Cosunter Pharmaceutical, showcasing their recent innovations and technological advancements.

Last updated on: Sep 30, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Fujian Cosunter Pharmaceutical

Sep 30, 2020Pyridone Compound As C-Met InhibitorGranted And Under Opposition

Explore Fujian Cosunter Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 30, 2020Pyridone Compound As C-Met Inhibitor1

Latest PTAB cases involving Fujian Cosunter Pharmaceutical

Discover the latest PTAB cases involving Fujian Cosunter Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Fujian Cosunter Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
FUJIAN COSUNTER PHARMACEUTICAL - 1 - - Non-Active
MERCK PATENT3425 - - Aggressive